NCT06921551

Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: ABLE Human Motion S.L. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is: Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis? Participants will: * Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic * Have an evaluation (tests and questionnaires) every 3 months at the clinic

Conditions

• Multiple Sclerosis

Interventions

Type	Name	Description
DEVICE	ABLE Exoskeleton	Participants will undergo 60-min gait training sessions with the exoskeleton once a week for up to12 months

Timeline

• Start date: 2025-04-07
• Primary completion: 2026-05-07
• Completion: 2026-05-07
• First posted: 2025-04-10
• Last updated: 2026-01-27

Locations

1 site across 1 country: Spain